RSS 1.0Allergy/Pulmonary & Critical Care Medicine
The Division has activities in two hospitals, Vanderbilt University Hospital and the Nashville Veterans Administration Hospital. Specialized clinical programs include a Cystic Fibrosis Center, Lung Transplantation,
Collections in this community
Recent Submissions
-
(Pulmonary Circulation, 2023-01-11)The considerable progress made in recent years in the diagnosis, risk stratification, and treatment of pulmonary hypertension was highlighted during the most recent edition of the Pulmonary Hypertension Association Scientific ...
-
(Annals Of Surgery, 2023-01-28)Objective:The aim of this review was to review the ethical and multidisciplinary clinical challenges facing trauma surgeons when resuscitating patients presenting with penetrating brain injury (PBI) and multicavitary trauma. ...
-
(Chest, 2022-06-15)BACKGROUND: Combination intrapleural fibrinolytic and enzyme therapy (IET) has been established as a therapeutic option in pleural infection. Despite demonstrated efficacy, studies specifically designed and adequately ...
-
(Pulmonary Therapy, 2022-12-08)Adults with obesity may develop asthma that is ineffectively controlled by inhaled corticosteroids and long-acting beta-adrenoceptor agonists. Mechanistic and translational studies suggest that metabolic dysregulation that ...
-
(Intensive Care Medicine, 2020-02)Purpose The aim of the RUBY study was to evaluate novel candidate biomarkers to enable prediction of persistence of renal dysfunction as well as further understand potential mechanisms of kidney tissue damage and repair ...
-
(BMJ Open Respiratory Research, 2019-02)Introduction Nintedanib slows disease progression in patients with idiopathic pulmonary fibrosis (IPF) by reducing the rate of decline in forced vital capacity, with an adverse event profile that is manageable for most ...
-
(Respiratory Reserarch, 2019-06-10)BackgroundSingle birth cohort studies have been the basis for many discoveries about early life risk factors for childhood asthma but are limited in scope by sample size and characteristics of the local environment and ...
-
(Lancet Respiratory Medicine, 2019-06)Background There is an urgent need for biomarkers to better stratify patients with idiopathic pulmonary fibrosis by risk for lung transplantation allocation who have the same clinical presentation. We aimed to investigate ...
-
(Annals of the American Thoracic Society, 2019-07)Retrospective administrative claims database studies provide real-world evidence about treatment patterns, healthcare resource use, and costs for patients and are increasingly used to inform policy-making, drug formulary, ...
-
(Annals of the American Thoracic Society, 2019-07)To the Editor: Idiopathic pulmonary fibrosis (IPF) is a debilitating, progressive, fatal, fibrosing lung disease (1, 2). Pirfenidone and nintedanib are oral antifibrotics with demonstrated efficacy in reducing lung ...
-
(Marine Druges, 2019-03)Angiotensin I-converting enzyme (ACE) inhibitory peptides derived from seaweed represent a potential source of new antihypertensive. The aim of this study was to isolate and purify ACE inhibitory peptides (ACEIPs) from the ...
-
(FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2019-07-03)The conserved oligomeric complex (COG) is a multi-subunit vesicle tethering complex that functions in retrograde trafficking at the Golgi. We have previously demonstrated that the formation of enlarged endo-lysosomal ...
-
(FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2019-07-03)The conserved oligomeric complex (COG) is a multi-subunit vesicle tethering complex that functions in retrograde trafficking at the Golgi. We have previously demonstrated that the formation of enlarged endo-lysosomal ...
-
(FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2019-07-03)The conserved oligomeric complex (COG) is a multi-subunit vesicle tethering complex that functions in retrograde trafficking at the Golgi. We have previously demonstrated that the formation of enlarged endo-lysosomal ...
-
Oral Tresprostinil in Transition or as Add-on Therapy in Pediatric Pulmonary Arterial hypertension (Pulmonary Circulation, 2019-07-12)Treprostinil, a prostacyclin analogue, is approved for the treatment of pulmonary arterial hypertension (PAH) in adults. Transition from parenteral to oral treprostinil has been successfully accomplished in adults with PAH ...
-
(American Journal of Respiratory and Critical Care Medicine, 2019-07-15)Over the past decade, several large registries of patients with idiopathic pulmonary fibrosis (IPF) have been established. These registries are collecting a wealth of longitudinal data on thousands of patients with this ...